GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Orchid Pharma Ltd

Orchid Pharma Board Meeting to Approve Q2 FY27 Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 11 Nov 2026, 05:30 PM IST  ·  BSE ID: ea9a4848-9c4a-4a1f-93a0-54fdaa494c6f
View Original BSE Filing (PDF)
💡
In Simple Terms
Orchid Pharma's board will meet on November 14, 2026, to finalize its financial results for July-September 2026.
🤖 AI Summary
  • Orchid Pharma's Board of Directors will convene on November 14, 2026, to approve Q2 FY27 financial results.
  • The board meeting will consider Unaudited Limited Reviewed Financial Results for quarter and half year ended September 30, 2026.
  • Trading window for company securities closed from October 01, 2026, as per SEBI regulations.
  • Trading window will reopen 48 hours after the declaration of the financial results.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this intimation.
👤
Who Is Affected
Shareholders will be affected by the subsequent financial results announcement, which will provide an update on the company's performance for Q2 FY27 and the half year ended September 30, 2026.
🔍
Management Signal
The intimation signals management's adherence to regulatory timelines for disclosing financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Board meeting outcome — wait for official Q2 FY27 financial results declaration.
Detailed Q2 FY27 financial statements — analyze revenue, profit, and balance sheet changes.
Company disclosures on investor call schedule following results announcement.
LOW RISK This filing is a routine board meeting intimation, carrying no immediate financial or operational risks.
💡 Investor Takeaway
Orchid Pharma has scheduled a Board Meeting for November 14, 2026, to consider and approve the Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) for Q2 FY27 and the half year ended September 30, 2026. No financial numbers were disclosed in this intimation.
❓ Frequently Asked Questions
When is Orchid Pharma Limited's next Board Meeting?
Orchid Pharma Limited's Board of Directors meeting is scheduled for Saturday, November 14, 2026.
What is the purpose of Orchid Pharma's Board Meeting on November 14, 2026?
The meeting is being held to consider and approve the Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) for Quarter-II and half year ended on September 30, 2026.
When did the trading window close for Orchid Pharma Limited?
The trading window for Orchid Pharma Limited's securities closed from October 01, 2026, and will remain closed until 48 hours after the financial results declaration.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.